At Targeted Solutions AG, we offer a comprehensive suite of services designed to support pharmaceutical companies in Low and Middle-Income Countries (LMICs). We are committed to enhancing global health outcomes by facilitating the transfer of pharmaceutical technologies.
Through strategic partnerships and a relentless commitment to our clients, we aim to ensure the accessibility and affordability of essential medications worldwide.
Assisting pharmaceutical companies in LMICs with the submission of drug dossiers to highly regulated agencies like MHRA and EMA, leveraging Marketing Authorisation to expedite approval processes.
Conducting and supporting research initiatives focused on repurposing small molecules and developing accessible drug formulations for LMICs.
Providing support and advisory services to facilitate the transfer of pharmaceutical technologies and innovations to market, especially in LMICs.
Offering workshops, training sessions, and continuing education programs tailored to the pharmaceutical industry's needs, focusing on regulatory compliance and market access.
Coordinating and managing projects to enhance drug availability in LMICs, from conception to regulatory approval and market launch.
Generating detailed reports and assessments to support drug approval submissions and to advise on regulatory strategies for entering new markets.
Providing statistical data analysis, modeling, and simulation services to support pharmaceutical product development, approval, and market positioning.
Advising and assisting with the publication of scientific research and developing communication strategies to engage stakeholders and promote public health initiatives.
Offering expert advice on navigating the complex regulatory landscape, ensuring compliance, and achieving successful drug approvals in various jurisdictions.
Assist in formulating and implementing innovative strategies to overcome barriers to medication access, focusing on sustainability and impact.
Building and maintaining a network among pharmaceutical companies, regulatory agencies, and health organizations to facilitate knowledge exchange and collaboration to improve global health outcomes.